 Connection
Ethan Lange to Disease Progression
This is a "connection" page, showing publications Ethan Lange has written about Disease Progression.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.053 |
|
|
|
-
Al-Sawaf O, Robrecht S, Bahlo J, Fink AM, Cramer P, V Tresckow J, Lange E, Kiehl M, Dreyling M, Ritgen M, D?rig J, Tausch E, Schneider C, Stilgenbauer S, Wendtner CM, Fischer K, Hallek M, Eichhorst B. Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials. Leukemia. 2021 01; 35(1):169-176.
Score: 0.027
-
F?rstenau M, Bahlo J, Fink AM, Lange E, Dreger P, Dreyling M, Hess G, Ritgen M, Kneba M, D?hner H, Stilgenbauer S, Wendtner CM, Goede V, Fischer K, B?ttcher S, Hallek M, Eichhorst B. Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemia. Leukemia. 2020 03; 34(3):924-928.
Score: 0.026
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|